Stockreport

Ra Pharmaceuticals Announces Positive gMG Phase 2 and Open-Label, Long-Term Extension Data at the 2019 AAN Annual Meeting

RA PHARMACEUTICALS  (RARX) 
Last ra pharmaceuticals earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rapharma.com/news-investors
PDF Open-label, long-term extension data show durability of zilucoplan treatment effect, with sustained improvements observed in primary and secondary endpoi [Read more]